ipriflavone has been researched along with Kidney Failure, Chronic in 2 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ipriflavone is a recently introduced anti-osteoporotic agent extensively metabolized to four major metabolites (M1, M2, M3, M5)." | 1.28 | Steady-state pharmacokinetics of ipriflavone and its metabolites in patients with renal failure. ( Acerbi, D; Rondelli, I; Ventura, P, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sugimura, T | 1 |
| Rondelli, I | 1 |
| Acerbi, D | 1 |
| Ventura, P | 1 |
2 other studies available for ipriflavone and Kidney Failure, Chronic
| Article | Year |
|---|---|
[Research on the treatment of secondary hyperparathyroidism as a complication of chronic renal failure].
Topics: Acid Phosphatase; Alkaline Phosphatase; Aluminum; Bone Density; Calcitonin; Calcitriol; Drug Adminis | 1991 |
Steady-state pharmacokinetics of ipriflavone and its metabolites in patients with renal failure.
Topics: Adult; Aged; Female; Humans; Isoflavones; Kidney Failure, Chronic; Male; Middle Aged; Osteoporosis | 1991 |